Clinical Trials Logo

Clinical Trial Summary

Association between plasma procalcitonin levels and positive blood cultures in critical illness patients in the ICU.

Clinical Trial Description

Rationale: Association of procalcitonin levels and blood cultures in critical illness patients on the ICU.

Objective: Procalcitonin is an acute phase protein. As part of the acute phase response, procalcitonin is produced during sepsis. Previous research shows that procalcitonin is a biomarker for bloodstream infection. However, there is still little known about the value of procalcitonin in diagnostics for micro-organism underlying a sepsis in ICU patients. In modern practice, blood cultures are taken when a patient is septic to determine the responsible micro-organism. When procalcitonin is a predictive value for bacteremia in the ICU, the number of blood cultures can be reduced.

Study design: An observational cohort study intervention: for each patient in the ICU blood cultures were taken, the procalcitonin level was determined. During 6 months 150 patients will be included.

Main study parameters/endpoints: this study will examine the predictive value of procalcitonin in blood cultures on the ICU. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03497741
Study type Observational
Source Rijnstate Hospital
Contact D Hoogeveen
Phone 088 005 3692
Status Recruiting
Start date October 1, 2017
Completion date April 1, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT02714595 - Study of S-649266 or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Recruiting NCT03644030 - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Recruiting NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Completed NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT03562689 - Cognitive Processing in Patients Surviving Delirium. Neuropsychological, EEG and Structural Brain Correlates.
Recruiting NCT02922998 - CD64 and Antibiotics in Human Sepsis N/A
Recruiting NCT02899143 - Short-course Antimicrobial Therapy in Sepsis Phase 2
Recruiting NCT02907931 - Carotid Doppler Ultrasound for the Measurement of Intravascular Volume Status N/A
Recruiting NCT02930070 - qSOFA in General Wards: the Accuracy in Diagnosis of Sepsis N/A
Recruiting NCT02565251 - Volemic Resuscitation in Sepsis and Septic Shock N/A
Recruiting NCT02567305 - Neutrophil Extracellular Traps and Neonatal (PV4991) & Pediatric Sepsis (PV5063) N/A
Completed NCT02467023 - Project 4B: Lower Extremity Strength Training in ICU Patients N/A
Recruiting NCT02914756 - HMGB1 in ICU-survivors N/A
Completed NCT02400697 - Placental Transfusion Project for Preterm Infants N/A
Completed NCT02883218 - Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis Patients
Completed NCT02079402 - Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Phase 4
Completed NCT02210169 - RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates N/A
Recruiting NCT02019992 - Investigation of Plasma Mitochondrial DNA Level in Septic Patients N/A